A Johnson & Johnson subsidiary barreled ahead this week with the filing of a Chapter 11 reorganization plan, even as a hearing looms to dismiss its entire bankruptcy.
The plan, filed late Monday, would resolve thousands of lawsuits alleging that Johnson & Johnson’s talcum powder products caused ovarian cancer and mesothelioma. But no sooner had bankrupt subsidiary LTL Management filed the plan then it came under attack.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
